company

BIOCON NORWAY LIMITED

0268 OSLO

Return on Equity
32,27 %
Current Ratio
2,32
Debt-to-Equity Ratio
0,03
Key figures (NOK)2022
Revenue2 890 000
Net Income457 000
Total Assets2 298 000
Total Equity1 416 000
Income (NOK)2022
Revenue2 890 000
Expenditure2 327 000
Operating Profit563 000
Financial Income1 000
Financial Costs−16 000
Financial Balance17 000
Earnings Before Tax580 000
Tax123 000
Net Income457 000
Balance (NOK)2022
Total Fixed Assets352 000
Total Current Assets1 946 000
Total Assets2 298 000
Total Retained Equity−393 000
Total Equity1 416 000
Total Long-Term Debt41 000
Total Current Debt840 000
Total Equity and Debt2 298 000
Cash flow (NOK)2022
Sales Income2 890 000
Other Income0
Revenue2 890 000
Cost of Goods Sold0
Salary Costs2 244 000
Depreciation0
Impairment0
Expenditure2 327 000
Operating Profit563 000
Financial Income1 000
Financial Costs−16 000
Financial Balance17 000
Dividends0
Net Income457 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets352 000
Total Fixed Assets352 000
Stock0
Total Investments248 000
Cash, Bank181 000
Total Current Assets1 946 000
Total Assets2 298 000
Total Equity1 416 000
Short-Term Group Debt237 000
Total Long-Term Debt41 000
Creditors0
Unpaid Taxes258 000
Dividends0
Other Current Debt217 000
Total Current Debt840 000
Total Equity and Debt2 298 000
Financial indicators2022
Return on Equity32,27 %
Debt-to-Equity Ratio0,03
Operating Profit Margin19,48 %
Current Ratio2,32
Quick Ratio2,32
Equity Ratio0,62
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English